Cerner offers their population health management software platform, HealtheIntent, their cloud-based data reconciliation and population stratification platform to provide a comprehensive population health management solution.
N/A
Red Arc
Score 9.0 out of 10
N/A
Red Arc builds apps that extend Blackbaud's Raiser's Edge NXT. These include a personalized letter writing tool, a Shopify connector, apps to enable calling directly from Raiser's Edge NXT, email marketing tool connectors, and other apps.
N/A
Pricing
Cerner HealtheIntent
Red Arc
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
Cerner HealtheIntent
Red Arc
Free Trial
No
No
Free/Freemium Version
No
Yes
Premium Consulting/Integration Services
No
No
Entry-level Setup Fee
No setup fee
No setup fee
Additional Details
—
—
More Pricing Information
Community Pulse
Cerner HealtheIntent
Red Arc
Features
Cerner HealtheIntent
Red Arc
Interoperability Platforms Features
Comparison of Interoperability Platforms Features features of Product A and Product B
Cerner HealtheIntent has been very reliable, as it hardly ever goes down. So it can be counted on. The end-user interface takes some time to get used to and could be better. Modules aren't always easy to find, making doing a certain task a bit cumbersome or taking more time to perform a task.
When Raiser's Edge initially discontinued direct integration with Microsoft Word, I was worried my time spent on exporting data, then reuploading into Word Merge would just increase and feel less productive. Red Arc filled the need for a receipting program that I don't have to leave RE NXT to use!
Metadata management in HealtheIntent should be improved. For example, we could find similar looking data sources (for example, diagnosis tables with similar names) but it was hard to distinguish and know which one is the one in production. It was because several data stewards loaded the same table with a different purpose (with similar tables names). And HealtheIntent doesn't have a metadata "for a test" or "for development", which makes hard to manage versions of one data source.
To run a SQL in HealtheIntent, there is a time limit of only 10 minutes. Also, there is no delicate configuration of query execution. It may not need a lot of functions like Toad or SQL developer, but what HealtheIntent provides is very limited.
Similar to the one above, HealtheIntent may need better metadata management for users. It is hard to find a table that I need, even to find out the existence of the table. Basic statistics like the size of a table, # of rows may be helpful for users.
I appreciate the free version, the support team was quick to respond when I was a new user with some questions, and it is pretty easy to use "out of the box"
Our organization had run Cerner EMR already so we only had a selection of adding HealtheIntent or not. There was no competitor. There are two aspects behind our decision: one is cost and the other is performance. We could save 50 full-time employee's expense to run our legacy analytics framework. I have no idea of details of the contract to buy and maintain HealtheIntent but generally speaking, it is saving money. Second, performances in terms of populating, processing data in HealtheIntent is way better than that of the legacy system.
ROI may be depending on the contract. But even if an organization is spending the same money for either homegrown analytics or HealtheIntent, HealtheIntent provides more agility of project or cost spending. If you don't like it you can discontinue anytime.
The negative one is, HealtheIntent is a new product in Cerner and at this point, it may not be capable of everything like homegrown analytics. The question would be the future of HealtheIntent and will be able to cover what you need soon.
If an organization is pursuing a standard, generic analytics and reporting (such as the combination of Oracle and Tableau), HealtheIntent is great. If not (for example, running R and d3.js for specific cases), the cost of migration to HealtheIntent will skyrocket.
